Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BNTX save search
Understanding the mRNA Therapeutics Market's -8.6% Decline: Insights from BCC Research
Published: 2024-04-10 (Crawled : 14:30) - prnewswire.com
OMGA | $2.565 6.43% 6.04% 390K
|
|
| O: -0.33%
H: 0.17%
C: 0.0%
CVAC | $2.57 -3.57% -3.7% 920K
|
Health Technology
|
| O: -0.67%
H: 1.36%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -1.69%
H: 0.97%
C: 0.14%
mrna research therapeutics
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
Published: 2024-04-07 (Crawled : 20:20) - globenewswire.com
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 1.38%
H: 0.2%
C: -1.27%
candidate cancer pancreatic tumor immunotherapy for response show
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
Published: 2024-03-27 (Crawled : 20:00) - globenewswire.com
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -0.08%
H: 1.01%
C: -0.7%
MTNB | $0.192 -3.95% 0.0% 1.2M
|
Health Technology
|
| O: -3.38%
H: 2.32%
C: -3.25%
business update biopharma financial results
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Published: 2024-03-20 (Crawled : 11:00) - biospace.com/
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -5.51%
H: 1.33%
C: 1.2%
AUTL | $4.85 -0.21% -0.21% 790K
|
Health Technology
|
| O: 1.45%
H: 5.33%
C: 4.13%
year update financial results
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
Published: 2024-03-20 (Crawled : 10:00) - globenewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -1.58%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.62%
H: 0.45%
C: 0.34%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -5.51%
H: 1.33%
C: 1.2%
management commercial
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published: 2024-03-18 (Crawled : 14:00) - prnewswire.com
CVAC | $2.57 -3.57% -3.7% 920K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.73%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.48%
H: 1.18%
C: 0.08%
ABUS | $2.79 -4.45% -4.66% 710K
|
Health Technology
|
| O: 0.38%
H: 0.38%
C: -3.42%
report genomic market
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
Published: 2024-03-14 (Crawled : 11:00) - globenewswire.com
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.11%
H: 0.3%
C: -1.21%
AUTL | $4.85 -0.21% -0.21% 790K
|
Health Technology
|
| O: 1.82%
H: 12.19%
C: 2.15%
business year therapeutics financial results
BNTX DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
NARI | News | $38.69 -1.05% -1.06% 650K
|
Health Technology
|
| O: -0.43%
H: 2.53%
C: -1.41%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
deadline
CMAX ALERT: Levi & Korsinsky, LLP Commences an Investigation of CareMax, Inc. (CMAX) f/k/a Deerfield Healthcare Technology Acquisitions Corp. (DFHT)
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
CMAX | $2.505 -14.51% -16.97% 80K
|
Manufacturing
|
| O: -0.61%
H: 4.46%
C: -10.62%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
acquisitions technology
ALVR IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
ALVR | $0.7521 2.34% 2.29% 570K
|
Health Technology
|
| O: -0.14%
H: 1.49%
C: -1.43%
deadline global
CTXTQ ALERT: Levi & Korsinsky, LLP Commences an Investigation of Cyxtera Technologies, Inc. (CYXTQ) f/k/a Starboard Value Acquisition (SVAC)
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
acquisition
EAF INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on March 25, 2024 in Securities Fraud Class Action Lawsuit Filed against GrafTech International Ltd.
Published: 2024-03-12 (Crawled : 01:00) - prnewswire.com
EAF | $1.49 -5.7% -1.34% 2.6M
|
Producer Manufacturing
|
| O: -0.56%
H: 8.38%
C: 4.47%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.54%
H: 0.18%
C: -1.13%
international deadline
Kessler Topaz Meltzer & Check, LLP Investigates The Chemours Company for Potential Securities Violations and Encourages Investors to Contact Firm
Published: 2024-03-11 (Crawled : 23:00) - prnewswire.com
AMPL | News | $9.505 -1.71% -1.74% 240K
|
|
| O: 0.27%
H: 0.54%
C: -0.63%
CC | News | $26.37 -0.15% 0.0% 1.1M
|
Process Industries
|
| O: -0.34%
H: 1.38%
C: 0.27%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.54%
H: 0.18%
C: -1.13%
company potential
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
Published: 2024-03-11 (Crawled : 12:00) - globenewswire.com
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -0.19%
H: 7.03%
C: 5.71%
ADM Investors Have Opportunity to Lead Archer-Daniels-Midland Company Securities Fraud Lawsuit
Published: 2024-03-08 (Crawled : 16:00) - prnewswire.com
ADM | $60.42 0.25% 0.0% 2.4M
|
Process Industries
|
| O: -0.07%
H: 1.9%
C: 1.11%
BROG | $1.105 -7.14% -7.69% 370K
|
Finance
|
| O: 5.66%
H: 6.59%
C: 6.59%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.0%
H: 0.48%
C: 0.2%
company
BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit
Published: 2024-03-08 (Crawled : 16:00) - prnewswire.com
BTAFF | $28.01 44.6% 2K
|
Consumer Non-Durables
|
| O: 0.5%
H: 0.13%
C: -0.94%
BTI | $28.59 0.74% 0.11% 3.9M
|
Consumer Non-Durables
|
| O: -0.07%
H: 0.58%
C: 0.44%
DADA | $1.835 -3.42% -3.54% 1.2M
|
Technology Services
|
| O: 1.63%
H: 0.58%
C: -7.6%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.0%
H: 0.48%
C: 0.2%
Kessler Topaz Meltzer & Check, LLP Reminds BioNTech SE Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm
Published: 2024-03-07 (Crawled : 22:00) - prnewswire.com
MBLY | $30.93 2.66% 2.59% 3.1M
|
|
| O: 1.06%
H: 0.49%
C: -3.77%
AMPL | News | $9.505 -1.71% -1.74% 240K
|
|
| O: 1.08%
H: 0.89%
C: -1.38%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.0%
H: 0.48%
C: 0.2%
deadline
BioNTech Announces Planned Retirement of Sean Marett
Published: 2024-03-07 (Crawled : 12:00) - globenewswire.com
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.0%
H: 0.55%
C: -0.33%
Lost Money on BioNTech SE(BNTX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
Published: 2024-03-07 (Crawled : 11:00) - prnewswire.com
AMLX | $1.99 -1.0% -1.01% 1.7M
|
|
| O: -0.68%
H: 1.37%
C: 0.26%
INMD | News | $17.45 -0.97% -0.97% 950K
|
Health Technology
|
| O: 0.88%
H: 0.52%
C: -1.26%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.0%
H: 0.55%
C: -0.33%
BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024
Published: 2024-03-06 (Crawled : 12:00) - globenewswire.com
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.64%
H: 1.11%
C: 0.32%
report year update financial results
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.